Navigation Links
Bumble Bee Foods Launches BeeWell Miles; An Interactive Health and Wellness Program Benefitting the Y-Me National Breast Cancer Foundation
Date:5/1/2008

(R) and Beach Cliff(R). The Bumble Bee brand has established significant consumer awareness and loyalty based on the superior quality of its protein products. For more information on Bumble Bee, visit http://www.bumblebee.com.

About Y-ME

Y-ME National Breast Cancer Organization's mission is to ensure, through information, empowerment and peer support, that no one faces breast cancer alone. Y-ME has the only 24-hour hotline staffed entirely by trained breast cancer survivors. Additionally, affiliates throughout the nation provide services such as support groups, early detection workshops, wigs and prostheses for women with limited resources and advocacy on breast cancer related policies.


'/>"/>
SOURCE Bumble Bee Foods
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Scientists Develop Natural Protection for Stored Foods
2. September: Time to Try Cholesterol-Free Soyfoods
3. Cutting Salt Wont Affect Foods Safety
4. American Diabetes Association and Goya Foods Inc. Team Up To Support Diabetes Awareness and Outreach in the Latino Community
5. Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations
6. Eating AGE-Rich Foods Causes Dysfunction Linked to Heart Disease
7. Whole Foods Market(R) Helps Shoppers Understand the Benefits of Natural Cosmetics
8. Pressure to Promote Healthier Eating to Cause Minor Growing Pains for Kids Licensed Foods and Beverages
9. Food 4 Less/Foods Co Pink Tag Campaign to Raise $150,000 for Breast Cancer Awareness in October
10. Healthy Living Made Easy with New Diabetes Foodsmart e-Newsletter
11. Stop & Shop Alerts Customers to Product Advisory by ConAgra Foods
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Know the Warning Signs of Stroke 2Health News:Know the Warning Signs of Stroke 3Health News:Know the Warning Signs of Stroke 4Health News:Researchers find roadmap to next-generation cancer therapies 2Health News:Americans believe wounded Iraq war veterans are not receiving high quality medical care in US 2Health News:Americans believe wounded Iraq war veterans are not receiving high quality medical care in US 3Health News:Drowsy Drivers Make Holiday Weekend Among the Most Dangerous 2Health News:Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking 2Health News:Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking 3Health News:Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking 4
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 1COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 2Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 1Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 1Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 4